Back to search
FDAFDA · Food and drugs·Recall number D-1082-2015

NITROFURANTOIN MONOHYDRATE/MACROCRYSTALS CAPSULES, 100 mg, 100 count bottle, Rx Only --- Distributed by Alvogen, Inc. Pine Brook, NJ 07058; NDC 47781-303-01

Published May 20, 2015 · Recall initiated: April 21, 2015

Summary

FDA records drug Class II recall D-1082-2015, published May 20, 2015 and initiated April 21, 2015. Recalling firm: Alvogen, Inc; Status: Terminated; Reported quantity: 13,392 bottles (100 count); Lot: Lot 457529, exp. 08/2016. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Failed Dissolution Specification; 6 month time point

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Brand
NITROFURANTOIN MONOHYDRATE/ MACROCRYSTALLINE
Manufacturer
Alvogen, Inc
Distributor
Nationwide and Puerto Rico
UPC
0347781303013
Lot
Lot 457529, exp. 08/2016
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was NITROFURANTOIN MONOHYDRATE/MACROCRYSTALS CAPSULES, 100 mg, 100 count bottle, Rx Only --- Distributed by Alvogen, Inc. Pine Brook, NJ 07058; NDC 47781-303-01 recalled?

Yes. FDA published recall D-1082-2015 on May 20, 2015. Reported hazard: Failed Dissolution Specification; 6 month time point

What should I do if I have this product?

Voluntary: Firm initiated · Letter

How do I know if my unit is part of the recall?

Compare your product details with the notice. Brand: NITROFURANTOIN MONOHYDRATE/ MACROCRYSTALLINE. UPC: 0347781303013.